These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 19342071)
1. Impact of a single amino acid in the variable region 2 of the Old World monkey TRIM5alpha SPRY (B30.2) domain on anti-human immunodeficiency virus type 2 activity. Kono K; Bozek K; Domingues FS; Shioda T; Nakayama EE Virology; 2009 May; 388(1):160-8. PubMed ID: 19342071 [TBL] [Abstract][Full Text] [Related]
2. Comparison of anti-viral activity of rhesus monkey and cynomolgus monkey TRIM5alphas against human immunodeficiency virus type 2 infection. Kono K; Song H; Shingai Y; Shioda T; Nakayama EE Virology; 2008 Apr; 373(2):447-56. PubMed ID: 18201746 [TBL] [Abstract][Full Text] [Related]
3. A dominant-negative effect of cynomolgus monkey tripartite motif protein TRIM5alpha on anti-simian immunodeficiency virus SIVmac activity of an African green monkey orthologue. Nakayama EE; Maegawa H; Shioda T Virology; 2006 Jun; 350(1):158-63. PubMed ID: 16647098 [TBL] [Abstract][Full Text] [Related]
4. Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction. Stremlau M; Perron M; Welikala S; Sodroski J J Virol; 2005 Mar; 79(5):3139-45. PubMed ID: 15709033 [TBL] [Abstract][Full Text] [Related]
5. Adaptive evolution of primate TRIM5alpha, a gene restricting HIV-1 infection. Liu HL; Wang YQ; Liao CH; Kuang YQ; Zheng YT; Su B Gene; 2005 Dec; 362():109-16. PubMed ID: 16226405 [TBL] [Abstract][Full Text] [Related]
6. A specific region of 37 amino acid residues in the SPRY (B30.2) domain of African green monkey TRIM5alpha determines species-specific restriction of simian immunodeficiency virus SIVmac infection. Nakayama EE; Miyoshi H; Nagai Y; Shioda T J Virol; 2005 Jul; 79(14):8870-7. PubMed ID: 15994780 [TBL] [Abstract][Full Text] [Related]
7. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Stremlau M; Owens CM; Perron MJ; Kiessling M; Autissier P; Sodroski J Nature; 2004 Feb; 427(6977):848-53. PubMed ID: 14985764 [TBL] [Abstract][Full Text] [Related]
8. TRIM5alpha-independent anti-human immunodeficiency virus type 1 activity mediated by cyclophilin A in Old World monkey cells. Nakayama EE; Shingai Y; Kono K; Shioda T Virology; 2008 Jun; 375(2):514-20. PubMed ID: 18367226 [TBL] [Abstract][Full Text] [Related]
9. Retrovirus restriction by TRIM5alpha variants from Old World and New World primates. Song B; Javanbakht H; Perron M; Park DH; Stremlau M; Sodroski J J Virol; 2005 Apr; 79(7):3930-7. PubMed ID: 15767395 [TBL] [Abstract][Full Text] [Related]
10. Rhesus monkey TRIM5alpha restricts HIV-1 production through rapid degradation of viral Gag polyproteins. Sakuma R; Noser JA; Ohmine S; Ikeda Y Nat Med; 2007 May; 13(5):631-5. PubMed ID: 17435772 [TBL] [Abstract][Full Text] [Related]
11. The B30.2(SPRY) domain of the retroviral restriction factor TRIM5alpha exhibits lineage-specific length and sequence variation in primates. Song B; Gold B; O'Huigin C; Javanbakht H; Li X; Stremlau M; Winkler C; Dean M; Sodroski J J Virol; 2005 May; 79(10):6111-21. PubMed ID: 15857996 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of HIV-1 replication by simian restriction factors, TRIM5alpha and APOBEC3G. Sakuma R; Noser JA; Ohmine S; Ikeda Y Gene Ther; 2007 Jan; 14(2):185-9. PubMed ID: 16943852 [TBL] [Abstract][Full Text] [Related]
13. All three variable regions of the TRIM5alpha B30.2 domain can contribute to the specificity of retrovirus restriction. Ohkura S; Yap MW; Sheldon T; Stoye JP J Virol; 2006 Sep; 80(17):8554-65. PubMed ID: 16912305 [TBL] [Abstract][Full Text] [Related]
14. Two surface-exposed elements of the B30.2/SPRY domain as potency determinants of N-tropic murine leukemia virus restriction by human TRIM5alpha. Perron MJ; Stremlau M; Sodroski J J Virol; 2006 Jun; 80(11):5631-6. PubMed ID: 16699044 [TBL] [Abstract][Full Text] [Related]
15. Rhesus monkey TRIM5α SPRY domain recognizes multiple epitopes that span several capsid monomers on the surface of the HIV-1 mature viral core. Biris N; Tomashevski A; Bhattacharya A; Diaz-Griffero F; Ivanov DN J Mol Biol; 2013 Dec; 425(24):5032-44. PubMed ID: 23886867 [TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of human TRIM5alpha on HIV-1 production. Zhang X; Kondo M; Chen J; Miyoshi H; Suzuki H; Ohashi T; Shida H Microbes Infect; 2010 Sep; 12(10):768-77. PubMed ID: 20493962 [TBL] [Abstract][Full Text] [Related]
18. Glycan deletions in the HIV-1 gp120 V1/V2 domain compromise viral infectivity, sensitize the mutant virus strains to carbohydrate-binding agents and represent a specific target for therapeutic intervention. Auwerx J; François KO; Covens K; Van Laethem K; Balzarini J Virology; 2008 Dec; 382(1):10-9. PubMed ID: 18930512 [TBL] [Abstract][Full Text] [Related]
19. Recognition of the HIV capsid by the TRIM5α restriction factor is mediated by a subset of pre-existing conformations of the TRIM5α SPRY domain. Kovalskyy DB; Ivanov DN Biochemistry; 2014 Mar; 53(9):1466-76. PubMed ID: 24506064 [TBL] [Abstract][Full Text] [Related]
20. A single amino acid of human immunodeficiency virus type 2 capsid protein affects conformation of two external loops and viral sensitivity to TRIM5α. Miyamoto T; Yokoyama M; Kono K; Shioda T; Sato H; Nakayama EE PLoS One; 2011; 6(7):e22779. PubMed ID: 21829511 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]